Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Invests $200 Million For Manufacturing Plant In China Medical City

Oct 11 2011

• By PharmAsia News

Related Content

Today Asia, Tomorrow The World? AstraZeneca Looks To Align R&D Strategy Across Emerging Markets

Jul 25 2011

Takeda Unveils R&D, Commercial Realignments To Try For Post-Patent Gains

May 11 2011

AstraZeneca R&D VP Steve Yang On Building R&D Success In Emerging Markets: An Interview With PharmAsia News (Part 1 of 2)

Jun 23 2011

China's Medical Exports And Imports Nearly Double In First Half 2011

Sep 15 2011

Big Pharma Takes Another Haircut As China Slashes Drug Prices In Two Largest Therapy Fields

Mar 08 2011

With Government Support, China Medical City Looks To Separate Itself From The Pack

Aug 03 2011

Pfizer, Roche, AstraZeneca: Emerging Markets Earnings Roundup (Part 3)

Feb 18 2011

Expansion Into China's Lower-tier Cities Could Be Growth Driver For Big Pharma

Feb 24 2011

As Pfizer Deal Speeds Up, Aurobindo Tangos With AstraZeneca For Branded Generics Play In Emerging Markets

Sep 07 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window